Young You Corporation Recalls Weight Loss Pills Found to Contain an Undeclared Drug Ingredient

Young You Corporation has been informed by the Food and Drug Administration (FDA) that four weight loss dietary supplements sold and marketed by the firm contain an undeclared drug ingredient. FDA lab analyses of dietary supplements distributed by the company were found to contain undeclared Sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss. The FDA has not approved the following products as drugs; therefore the safety and effectiveness of this product is unknown.

All lots of the following dietary weight loss supplement products are being recalled:
Slimbionic – 30 Capsules/Box – Sibutramine
One Weight Loss Pill – 30 capsules – 30 Capsules/Bottle – Sibutramine
SlimDemand Capsules – 30 Capsules/Box – Sibutramine
Botanical Weight Loss – 30 Capsules/Box – Sibutramine

The products listed above were sold and distributed nationwide via the internet and at the company’s Weight Loss and Rejuvenation Center in Tarzana.

FDA advises that these products pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

No illnesses or injuries have been reported to the company to date in connection with this product.

Young You Corp. has taken this voluntary action because it is committed to providing accurate information about its products and because of the concern for the health and safety of consumers. Young You Corp. is working with the FDA in the recall process. It sincerely regrets any inconvenience to customers.

Consumers are advised to destroy the above products or return them to the company’s address in Tarzana, CA. Consumers with questions may contact Young You Corp Monday through Friday 9:00 am to 5:30 pm at 818-344-3344.

Any adverse reactions experienced with the use of this product should also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at wwww.fda.gov/Safety/MedWatch/default.htm.